Expect audience representation from Roche, Pfizer, Shire, Boehringer Ingelheim, Takenda, Johnson & Johnson, Bayer Healthcare, Janssen, AstraZeneca and many more large and small pharma & biotech companies.
The event will consist of 80-100 senior and C-level delegates (by invitation only).
• 85% of D4 USA attendees are from pharmaceutical companies. The remaining attendees were mostly from academia (e.g. Stanford and Harvard) and FDA
BENEFITS OF PARTNERING
This conference will provide partners with opportunities to gather buyer and product intelligence, demonstrate trust and value, and generate highly relevant leads through the forming of new relationships.
Open the doors of new, previously impenetrable, prospects by demonstrating value and building trust.
Build and develop trusted relationships with key people in the target market.
Grow your sales pipeline and gather information not readily available to competitors.
STEER YOUR R&D
Gather actionable intelligence that will influence your R&D by understanding market needs.
REFINE YOUR SALES & MARKETING APPROACH
Gain an in-depth understanding of what buyers and influencers’ look for when evaluating new technology and making purchasing decisions.
Get unique access to end-users who are shaping the future.
LONGEVITY AND EXTENDED BENEFITS
Further exposure to the wider market through the post-meeting report.